“While the enthusiasm for shorter regimens is understandable, it should not override what people with TB say they need most: holistic therapy that acknowledges their humanity at every step.” A comment, published in The Lancet Infectious Diseases, reflects on treatment characteristics that people with TB value most and underlines that quality of care is as important as duration of treatment, pointing out the pitfalls behind the “one-size-fits-all” model of TB treatment.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #17, 23 May 2025).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and EATG. Subscribe to the newsletter here.
Source : The Lancet Infectious Diseases
Related HIV and Co-Infections News
-
U.S. Department of State: America First Global Health Strategy – bilateral agreements with Nigerian, Cameroon and Mozambique
-
The potential of new TB vaccines offers hope at the Union Conference in a year of crisis
-
[Press release] WHO releases guidance on evidence generation on new regimens for TB preventive treatment
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.